Tag: Atea Pharmaceuticals

Clinical Trials, Research and Development

Atea and Roche’s COVID-19 antiviral flunks phase 2, prompting switch that will delay pivotal data

October 19, 2021

Via: FierceBiotech

Atea Pharmaceuticals and Roche have suffered a big blow to their bid to bring an oral antiviral for COVID-19 to market. A phase 2 trial of the candidate missed its primary endpoint, prompting Atea and Roche to consider changes that […]